
    
      This transplant protocol will test the following: 1) the ability to achieve engraftment with
      the reduced intensity protocol, 2) the mortality associated with transplant by day 100, 3)
      patient outcomes, based on differential imaging and biologic evaluations prior to
      transplantation and at designated points after transplantation (day 100, 6 months, 1, 2 and 5
      years). Additional biologic studies will include microarray analysis, Campath levels just
      prior to the administration of the graft, and establishment of mesenchymal stem cell lines.
      In older patients, studies to evaluation osteoclast differentiation and function will also be
      offered.
    
  